In today's views

• Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
• MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
• ​CICH | 9M25 resilience underscores our EGP13/share fair value
• TWSA | Preliminary indicators show promising growth in factoring

In today's views

• Strategy | MCRO 19% share price rally has pushed 2026 earnings multiples to sector average. Time to exercise caution.
• MFPC | Urea prices likely to decline as cost curve shifts

*Key Views for today*

• Strategy | Tuk Tuk replacement program is outright "Qute" for GB Auto, GB Capital and financial inclusion.
• ISPH | Government arrears clearance eases working-capital pressure; valuation remains attractive
• MPRC | Eyeing a potential land monetization story as Egypt announces a new media city near the pyramids.
• ALCN | ADP’s move goes beyond a stake; Strategic control, port integration, and multi-market synergies

In today's Pre-Session Views:

• Strategy | Spinney's Egypt deal and the simple math of value show that ISPH should be trading at EGP15/share
• ADIB | The simple math of a capital increase
• JUFO | Export mix reweighting and positioning for 2026 volume recovery
• EKHO | Results call highlights new UK pyrolysis project; operational resilience and capital recycling underscore upside potential
• ORWE | Maintains 2025 guidance, discusses restructuring and dividends; we remain neutral on 2026 outlook